Indo-Bangla Pharmaceuticals (DHA:IBP) YoY EPS Growth: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT16.00
View Full Analysis

What is Indo-Bangla Pharmaceuticals YoY EPS Growth?

Indo-Bangla Pharmaceuticals DHA:IBP -2.45% 32 YoY EPS Growth is 0.00% as of . 20. GuruFocus rates DHA:IBP with a GF Score™ of 32/100.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Indo-Bangla Pharmaceuticals's YoY EPS Growth for the quarter that ended in . 20 was 0.00%.

Indo-Bangla Pharmaceuticals's Earnings per Share (Diluted) for the six months ended in . 20 was BDT0.00.

Indo-Bangla Pharmaceuticals YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals YoY EPS Growth Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
YoY EPS Growth

Indo-Bangla Pharmaceuticals Semi-Annual Data
YoY EPS Growth
DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Indo-Bangla Pharmaceuticals's YoY EPS Growth for the fiscal year that ended in . 20 is calculated as:

YoY EPS Growth (A: . 20 )
=(Earnings per Share (Diluted) (A: . 20 )-Earnings per Share (Diluted) (A: . 20 ))/ | Earnings per Share (Diluted) (A: . 20 ) |
=(-)/ | |
=N/A %

Indo-Bangla Pharmaceuticals's YoY EPS Growth for the quarter that ended in . 20 is calculated as:

YoY EPS Growth (Q: . 20 )
=(Earnings per Share (Diluted) (Q: . 20 )-Earnings per Share (Diluted) (Q: . 20 )) / | Earnings per Share (Diluted) (Q: . 20 ) |
=(-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 0.00% mean?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a YoY EPS Growth of 0.00% as of . 20. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Indo-Bangla Pharmaceuticals and its competitors.
Is Indo-Bangla Pharmaceuticals' YoY EPS Growth too high?
Indo-Bangla Pharmaceuticals' current YoY EPS Growth is 0.00%. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Indo-Bangla Pharmaceuticals' YoY EPS Growth compare to ?
Indo-Bangla Pharmaceuticals' YoY EPS Growth of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Drug Manufacturers company?
A good YoY EPS Growth depends on the Drug Manufacturers industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Indo-Bangla Pharmaceuticals and its competitors. Indo-Bangla Pharmaceuticals's current YoY EPS Growth is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo-Bangla Pharmaceuticals stock overvalued right now?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a current YoY EPS Growth of 0.00%. The current YoY EPS Growth is 0.00%. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current YoY EPS Growth is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT16.00
Price